UB Paderborn / Katalog / Suche / in CDI

Is the approach to therapy of AL-amyloidosis changing--editorial

Vnitřní lékar̆stvĭ, 2013-02, Vol.59 (2), p.96-98

Elbl, L

2013

Link zum Volltext

Verfügbarkeit prüfen

Not Available

Vnitřní lékar̆stvĭ, 2013-11, Vol.59 (11), p.949-951

2013

Link zum Volltext

Verfügbarkeit prüfen

Uloha biomarkeru v casne diagnostice kardiotoxicity onkologicke lecby - editorial

Vnitřní lékar̆stvĭ, 2013-11, Vol.59 (11), p.949

2013

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Acute and Early Cardiotoxicity in Survivors of Hodgkin's Disease Treated with ABVD or BEACOPP Regimens

Journal of chemotherapy (Florence), 2006-04, Vol.18 (2), p.199-208

2006

Link zum Volltext

Verfügbarkeit prüfen

P1145 The late consequences of anthracycline treatment on the left-ventricular function in patients treated for childhood cancer

European heart journal, 2003-03, Vol.24 (5), p.211

ELBL, L

2003

Link zum Volltext

Verfügbarkeit prüfen

Cardiac function and cardiopulmonary performance in patients after treatment for non-Hodgkin's lymphoma

Neoplasma, 2006, Vol.53 (2), p.174

2006

Link zum Volltext

Verfügbarkeit prüfen

Echocardiographic evaluation of early and chronic cardiotoxicity in adult patients treated for Hodgkin's disease with ABVD regimen

Neoplasma, 2006, Vol.53 (1), p.62

2006

Link zum Volltext

Verfügbarkeit prüfen

The evaluation of left ventricular function in childhood cancer survivors by pharmacological stress echocardiography

Neoplasma, 2003, Vol.50 (3), p.191

2003

Link zum Volltext

Verfügbarkeit prüfen

Apolipoprotein B signal peptide polymorphism in relation to lipids and diabetes in male CAD patients

Atherosclerosis, 2000-09, Vol.152 (1), p.257-258

2000

Link zum Volltext

Verfügbarkeit prüfen

Relation between the insertion/deletion polymorphism in the gene coding for receptor associated protein (RAP) and plasma apolipoprotein AI (apoAI) and high-density lipoprotein cholesterol (HDL) levels

Clinical genetics, 2000-04, Vol.57 (4), p.309-310

2000

Link zum Volltext

Verfügbarkeit prüfen

Late anthracycline cardiotoxicity protection by dexrazoxane (ICRF-187) in pediatric patients: echocardiographic follow-up

Supportive care in cancer, 2006-02, Vol.14 (2), p.128-136

2006

Link zum Volltext

Verfügbarkeit prüfen

The late consequences of anthracycline treatment on left ventricular function after treatment for childhood cancer

European journal of pediatrics, 2003-10, Vol.162 (10), p.690-696

2003

Link zum Volltext

Verfügbarkeit prüfen

Long-term serial echocardiographic examination of late anthracycline cardiotoxicity and its prevention by dexrazoxane in paediatric patients

European journal of pediatrics, 2005-11, Vol.164 (11), p.678-684

2005

Link zum Volltext

Verfügbarkeit prüfen

Exercise testing in children and adolescents after completing anthracycline antitumour therapy

Scripta medica, 2006-01, Vol.79 (5-6), p.271-278

2006

Link zum Volltext

Verfügbarkeit prüfen

Cardiotoxicity of antineoplastic therapy: an extremely rare complication? Comment on the article by M. Vambera et al: "Cardiac damage in a young woman with Hodgkin's disease and long term survival after combination therapy and bone marrow transplantation"

Vnitřní lékar̆stvĭ, 2003-01, Vol.49 (1), p.23

Elbl, L

2003

Link zum Volltext

Verfügbarkeit prüfen

Disorders of the cardiovascular system during treatment of oncologic diseases

Vnitřní lékar̆stvĭ, 2002-07, Vol.48 (7), p.619

Elbl, L

2002

Link zum Volltext

Verfügbarkeit prüfen

Methylenetetrahydrofolate Reductase Polymorphism, Type II Diabetes Mellitus, Coronary Artery Disease, and Essential Hypertension in the Czech Population

Molecular genetics and metabolism, 2001-06, Vol.73 (2), p.188-195

2001

Link zum Volltext

Verfügbarkeit prüfen

392 Echocardiographic assessment of coronary flow reserve in patients with borderline stenosis of LAD. Comparison with exercise echocardiography

European journal of echocardiography, 2003-12, Vol.4, p.S48

2003

Link zum Volltext

Verfügbarkeit prüfen

The influence of rehabilitation on peak oxygen consumption in patients after myocardial infarction treated with beta-blockers

Vnitřní lékar̆stvĭ, 2008-03, Vol.54 (3), p.225-228

2008

Link zum Volltext

Verfügbarkeit prüfen

Acute heart failure and early development of left ventricular dysfunction in patients with ST segment elevation acute myocardial infarction managed with primary percutaneous coronary intervention

Vnitřní lékar̆stvĭ, 2011-01, Vol.57 (1), p.43-51

2011

Link zum Volltext

Verfügbarkeit prüfen

The C766T low-density lipoprotein receptor related protein polymorphism and coronary artery disease, plasma lipoproteins, and longevity in the Czech population

Journal of molecular medicine (Berlin, Germany), 2001-04, Vol.79 (2-3), p.116-120

2001

Link zum Volltext

Verfügbarkeit prüfen

Comparison of plasmatic levels of B-natriuretic peptide with echocardiographic indicators of left ventricle function after doxorubicin therapy

Vnitřní lékar̆stvĭ, 2006-06, Vol.52 (6), p.563

2006

Link zum Volltext

Verfügbarkeit prüfen

Late cardiotoxicity in patients with malignant lymphoma treated with doxorubicin chemotherapy

Vnitřní lékar̆stvĭ, 2006-04, Vol.52 (4), p.328

2006

Link zum Volltext

Verfügbarkeit prüfen

Single Effects of Apolipoprotein B, (a), and E Polymorphisms and Interaction between Plasminogen Activator Inhibitor-1 and Apolipoprotein(a) Genotypes and the Risk of Coronary Artery Disease in Czech Male Caucasians

Molecular genetics and metabolism, 2000-02, Vol.69 (2), p.137-143

2000

Link zum Volltext

Verfügbarkeit prüfen

Lower cardiotoxicity of adriamycin during continuous administration in patients with refractory multiple myeloma treated with cyclophosphamide, vincristine, adriamycin and dexamethasone (C-VAD)

Vnitřní lékar̆stvĭ, 1994-08, Vol.40 (8), p.506

1994

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Is the approach to therapy of AL-amyloidosis changing--editorial

Not Available

Uloha biomarkeru v casne diagnostice kardiotoxicity onkologicke lecby - editorial

Evaluation of Acute and Early Cardiotoxicity in Survivors of Hodgkin's Disease Treated with ABVD or BEACOPP Regimens

P1145 The late consequences of anthracycline treatment on the left-ventricular function in patients treated for childhood cancer

Cardiac function and cardiopulmonary performance in patients after treatment for non-Hodgkin's lymphoma

Echocardiographic evaluation of early and chronic cardiotoxicity in adult patients treated for Hodgkin's disease with ABVD regimen

The evaluation of left ventricular function in childhood cancer survivors by pharmacological stress echocardiography

Apolipoprotein B signal peptide polymorphism in relation to lipids and diabetes in male CAD patients

Relation between the insertion/deletion polymorphism in the gene coding for receptor associated protein (RAP) and plasma apolipoprotein AI (apoAI) and high-density lipoprotein cholesterol (HDL) levels

Late anthracycline cardiotoxicity protection by dexrazoxane (ICRF-187) in pediatric patients: echocardiographic follow-up

The late consequences of anthracycline treatment on left ventricular function after treatment for childhood cancer

Long-term serial echocardiographic examination of late anthracycline cardiotoxicity and its prevention by dexrazoxane in paediatric patients

Exercise testing in children and adolescents after completing anthracycline antitumour therapy

Cardiotoxicity of antineoplastic therapy: an extremely rare complication? Comment on the article by M. Vambera et al: "Cardiac damage in a young woman with Hodgkin's disease and long term survival after combination therapy and bone marrow transplantation"

Disorders of the cardiovascular system during treatment of oncologic diseases

Methylenetetrahydrofolate Reductase Polymorphism, Type II Diabetes Mellitus, Coronary Artery Disease, and Essential Hypertension in the Czech Population

392 Echocardiographic assessment of coronary flow reserve in patients with borderline stenosis of LAD. Comparison with exercise echocardiography

The influence of rehabilitation on peak oxygen consumption in patients after myocardial infarction treated with beta-blockers

Acute heart failure and early development of left ventricular dysfunction in patients with ST segment elevation acute myocardial infarction managed with primary percutaneous coronary intervention

The C766T low-density lipoprotein receptor related protein polymorphism and coronary artery disease, plasma lipoproteins, and longevity in the Czech population

Comparison of plasmatic levels of B-natriuretic peptide with echocardiographic indicators of left ventricle function after doxorubicin therapy

Late cardiotoxicity in patients with malignant lymphoma treated with doxorubicin chemotherapy

Single Effects of Apolipoprotein B, (a), and E Polymorphisms and Interaction between Plasminogen Activator Inhibitor-1 and Apolipoprotein(a) Genotypes and the Risk of Coronary Artery Disease in Czech Male Caucasians

Lower cardiotoxicity of adriamycin during continuous administration in patients with refractory multiple myeloma treated with cyclophosphamide, vincristine, adriamycin and dexamethasone (C-VAD)

Suchergebnisse filtern